These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 24493327)
21. Application of the MAT-CHDSP to assess guideline adherence and therapy goal achievement in secondary prevention of coronary heart disease after percutaneous coronary intervention. Garcia BH; Småbrekke L; Trovik T; Giverhaug T Eur J Clin Pharmacol; 2013 Mar; 69(3):703-9. PubMed ID: 22990329 [TBL] [Abstract][Full Text] [Related]
22. Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention. Loncar G; Barthelemy O; Berman E; Kerneis M; Petroni T; Payot L; Choussat R; Silvain J; Collet JP; Helft G; Montalescot G; Le Feuvre C Arch Cardiovasc Dis; 2015 Nov; 108(11):554-62. PubMed ID: 26184868 [TBL] [Abstract][Full Text] [Related]
23. Predictors of treatment in acute coronary syndromes in the elderly: impact on decision making and clinical outcome after interventional versus conservative treatment. Rittger H; Schnupp S; Sinha AM; Breithardt OA; Schmidt M; Zimmermann S; Mahnkopf C; Brachmann J; Rieber J Catheter Cardiovasc Interv; 2012 Nov; 80(5):735-43. PubMed ID: 22121113 [TBL] [Abstract][Full Text] [Related]
24. Impact of female sex on long-term acute coronary syndrome outcomes. Perl L; Bental T; Assali A; Vaknin-Assa H; Lev E; Kornowski R; Porter A Coron Artery Dis; 2015 Jan; 26(1):11-6. PubMed ID: 25144669 [TBL] [Abstract][Full Text] [Related]
25. Sustained sex-based treatment differences in acute coronary syndrome care: Insights from the American Heart Association Get With The Guidelines Coronary Artery Disease Registry. Udell JA; Fonarow GC; Maddox TM; Cannon CP; Frank Peacock W; Laskey WK; Grau-Sepulveda MV; Smith EE; Hernandez AF; Peterson ED; Bhatt DL; Clin Cardiol; 2018 Jun; 41(6):758-768. PubMed ID: 29521450 [TBL] [Abstract][Full Text] [Related]
26. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar. El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397 [TBL] [Abstract][Full Text] [Related]
27. Clinical Impact of Suboptimal Stenting and Residual Intrastent Plaque/Thrombus Protrusion in Patients With Acute Coronary Syndrome: The CLI-OPCI ACS Substudy (Centro per la Lotta Contro L'Infarto-Optimization of Percutaneous Coronary Intervention in Acute Coronary Syndrome). Prati F; Romagnoli E; Gatto L; La Manna A; Burzotta F; Limbruno U; Versaci F; Fabbiocchi F; Di Giorgio A; Marco V; Ramazzotti V; Di Vito L; Trani C; Porto I; Boi A; Tavazzi L; Mintz GS Circ Cardiovasc Interv; 2016 Dec; 9(12):. PubMed ID: 27965297 [TBL] [Abstract][Full Text] [Related]
29. Optimal in-hospital and discharge medical therapy in acute coronary syndromes in Kerala: results from the Kerala acute coronary syndrome registry. Huffman MD; Prabhakaran D; Abraham AK; Krishnan MN; Nambiar AC; Mohanan PP; Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):436-43. PubMed ID: 23800985 [TBL] [Abstract][Full Text] [Related]
30. The causes and outcomes of inadequate implementation of existing guidelines for antiplatelet treatment in patients with acute coronary syndrome: the experience from Taiwan Acute Coronary Syndrome Descriptive Registry (T-ACCORD Registry). Cheng CI; Chen CP; Kuan PL; Lei MH; Liau CS; Ueng KC; Wu CJ; Lai WT Clin Cardiol; 2010 Jun; 33(6):E40-8. PubMed ID: 20552592 [TBL] [Abstract][Full Text] [Related]
31. Gender difference in long-term clinical outcomes following percutaneous coronary intervention during 1984-2008. Naito R; Miyauchi K; Konishi H; Tsuboi S; Ogita M; Dohi T; Kasai T; Tamura H; Okazaki S; Isoda K; Daida H Atherosclerosis; 2016 Apr; 247():105-10. PubMed ID: 26896722 [TBL] [Abstract][Full Text] [Related]
32. The burden of major adverse cardiac events in patients with coronary artery disease. Tsai IT; Wang CP; Lu YC; Hung WC; Wu CC; Lu LF; Chung FM; Hsu CC; Lee YJ; Yu TH BMC Cardiovasc Disord; 2017 Jan; 17(1):1. PubMed ID: 28052754 [TBL] [Abstract][Full Text] [Related]
33. Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study. Pereira M; Araújo C; Dias P; Lunet N; Subirana I; Marrugat J; Capewell S; Bennett K; Azevedo A Eur J Prev Cardiol; 2014 Nov; 21(11):1401-8. PubMed ID: 23787795 [TBL] [Abstract][Full Text] [Related]
34. Twelve-month outcomes of patients unsuitable for prolonged DAPT presenting with an acute coronary syndrome and treated with polymer-free biolimus A9 drug-coated stents. Kinnaird T; Abdul F; Hailan A; Sheikh A; Hinton J; Yazji K; Elangovan S; Yousef A; Gallagher S; Choudhury A; Anderson R; O'Kane P; Smith D Catheter Cardiovasc Interv; 2018 Dec; 92(7):1220-1228. PubMed ID: 30244504 [TBL] [Abstract][Full Text] [Related]
35. Trends in optimal medical therapy prescription and mortality after admission for acute coronary syndrome: a 9-year experience in a real-world setting. Hoedemaker NPG; Damman P; Ottervanger JP; Dambrink JHE; Gosselink ATM; Kedhi E; Kolkman E; de Winter RJ; van 't Hof AWJ Eur Heart J Cardiovasc Pharmacother; 2018 Apr; 4(2):102-110. PubMed ID: 29394340 [TBL] [Abstract][Full Text] [Related]
36. Practice patterns and trends in the use of medical therapy in patients undergoing percutaneous coronary intervention in Ontario. Garg P; Wijeysundera HC; Yun L; Cantor WJ; Ko DT J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25122664 [TBL] [Abstract][Full Text] [Related]
37. Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: validation of the logistic clinical SYNTAX (Synergy Between Percutaneous Coronary Interventions With Taxus and Cardiac Surgery) score. Farooq V; Vergouwe Y; Généreux P; Bourantas CV; Palmerini T; Caixeta A; Garcìa-Garcìa HM; Diletti R; Morel MA; McAndrew TC; Kappetein AP; Valgimigli M; Windecker S; Dawkins KD; Steyerberg EW; Serruys PW; Stone GW JACC Cardiovasc Interv; 2013 Jul; 6(7):737-45. PubMed ID: 23866185 [TBL] [Abstract][Full Text] [Related]
38. Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study. Baber U; Chandrasekhar J; Sartori S; Aquino M; Kini AS; Kapadia S; Weintraub W; Muhlestein JB; Vogel B; Faggioni M; Farhan S; Weiss S; Strauss C; Toma C; DeFranco A; Baker BA; Keller S; Effron MB; Henry TD; Rao S; Pocock S; Dangas G; Mehran R JACC Cardiovasc Interv; 2017 Oct; 10(20):2017-2025. PubMed ID: 28780028 [TBL] [Abstract][Full Text] [Related]
39. Current statin usage for patients with acute coronary syndrome undergoing percutaneous coronary intervention: multicenter survey in Korea. Kim MJ; Jeon DS; Gwon HC; Kim SJ; Chang K; Kim HS; Tahk SJ; Clin Cardiol; 2012 Nov; 35(11):700-6. PubMed ID: 22825844 [TBL] [Abstract][Full Text] [Related]
40. Intra-procedural stent thrombosis: a new risk factor for adverse outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndromes. Brener SJ; Cristea E; Kirtane AJ; McEntegart MB; Xu K; Mehran R; Stone GW JACC Cardiovasc Interv; 2013 Jan; 6(1):36-43. PubMed ID: 23266233 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]